Survey ranks LifeCell as the most recommended Stem Cell Bank by Gynaecologists in India

Mumbai, 13 December 2012:

A recent survey conducted by Nielsen India amongst gynecologists in the country shows that LifeCell International enjoys the highest brand equity in comparison to key industry players. According to the survey, out of the leading stem cell banks in the country LifeCell has the highest brand recall at 85% with top of the mind position amongst Gynaecologists. The study also shows that LifeCell is recommended by Gynaecologists three times more than its closest competitor, making it the most recommended stem cell bank in India. From an industry point of view, the results reveal that over 99% of the gynecologists interviewed were aware about stem cell banking and 90% of them recommended the service to expectant parents.

The first of its kind industry research conducted by Nielsen amongst Gynaecologists in India assesses the brand preferences in the stem cell banking industry. The survey was conducted across 8 leading metros covering Mumbai, Ahmedabad, Bangalore, Chennai, Delhi, Hyderabad, Kolkata and Pune. It involved personal discussions with over 300 gynecologists who have been actively practicing in the field for more than 3 years.

Commenting on the results, Mr. Mayur Abhaya, Managing Director and CEO of LifeCell International said, “We are extremely proud to be recognized as India’s most recommended stem cell bank by Gynaecologists. When we launched our services in 2004 the concept was relatively new to the medical fraternity. The Nielsen study results are a milestone achievement with a majority of Indian Gynaecologists recommending LifeCell over three times as compared to other stem cell banks. Our approach has always been to provide our stakeholders value additions to the services backed with International accreditations. This has resulted in significant endorsement from Gynecologists displaying their confidence and trust on us.

KEY RESEARCH FINDINGS 100% 80% 60% Awareness about stem cell 40% banking 20% Recommend Stem Cell 0% Banking Awareness Recommend about stem Stem Cell cell banking Banking


Established in 2004, LifeCell is India’s first and largest stem cell storage company and holds the position of being the market leader with over 50,000 parents, including high profile celebrity couples who have banked their baby’s umbilical cord stem cells with the company. LifeCell has a strong pan-India presence with services extending to over 100 towns and cities in the country. Its preservation facility in Chennai is one of the most reputed in the industry with several national and international accreditations to its credit.

Stem cells derived from the umbilical cord are known to have the potential to treat over 75 serious medical conditions. Some of the conditions which can be treated include diseases such as blood cancer, thalassemia, brain injury, cerebral palsy and many more in the future. More and more people are now banking with LifeCell to preserve stem cells for potential need in the future. Stem Cell collection is a simple and non -invasive procedure that is safe for both women and newborn babies.

The stem cell banking market in India is pegged to be worth over 100 crores and is growing at 40% per annum, mainly driven by rising disposable incomes clubbed with increasing awareness. Yet, the Indian stem cell banking industry remains highly underpenetrated, with only less than 0.5% of the approximately 26 million births in India annually becoming part of stem-cell banking. LifeCell since its inception has been dedicated to raising awareness about stem cell banking through its persistent educative and promotional initiatives. To further enhance awareness, LifeCell alsogot on board Lisa Ray, a living example of successful stem cell therapy for treatment of cancer as their brand ambassador. She plays a vital role in talking to the masses about the importance of stem cell banking.

About LifeCell International

LifeCell is India’s largest & most accredited stem cell bank and the first to bring the revolutionary concept of umbilical cord stem cell banking to India in 2004 in technological collaboration with Cryo-Cell International. USA -the world’s first private stem cell bank LifeCell is headquartered at Chennai with an advanced laboratory & research facility in adherence to strict International guidelines. The stringent standards followed by LifeCell have received many International accreditations from AABB (American Association of Blood Banks), CAP (College of American Pathologists), and NABL (National Accreditation Z Board for Calibration and Testing Laboratories). LifeCell is the first stem cell bank in India to receive prestigious AABB accreditation for Cord blood & cord tissue. Importantly LifeCell is also the second in the world to be accredited for cord tissue preservation. Since inception LifeCell has grown at a consistent pace and has strongly established its leadership position in the industry, with its coverage extending to over 100 cities and towns in India. As leaders LifeCell had the responsibility of educating the public and medical fraternity on stem cell technology and through these efforts today over 50,000 parents have preserved their baby’s cord blood stem cells with LifeCell. Considering LifeCell’s leadership position and growth, the company was honoured as one amongst ‘India’s Most Promising Brand’ for 2011-2012 by 4Ps Business and Marketing. The company is also championing several initiatives in the stem cell therapy area through partnerships and in-house R&D efforts. LifeCell is the sole distributor for USFDA approved point-of-care medical device that can provide a patient’s stem cells from the bone marrow within 15 minutes from by the bed-side, which is useful for applications in orthopedic, vascular and cardiovascular specialties. With these significant achievements and leadership, LifeCell has uniquely positioned itself as a comprehensive stem cells solutions provider with a complete spectrum of services in stem cells through multi-service stem cell banking, R&D, clinical trials and stem cell therapy.

For more information log onto: